Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials

Nephrology Dialysis Transplantation

Volumn 10, Issue 11, 1995, Pages 1963-1974

  Gansevoort, R T ^a   Sluiter, W J ^a   Hemmelder, M H ^a   De Zeeuw, D ^a   De Jong, P E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Angiotensin converting enzyme inhibitors; Beta blocking agent; Calcium channel blockers; Comparative study; Meta analysis; Proteinuria

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; META ANALYSIS; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEINURIA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HUMAN; KIDNEY DISEASES; PROTEINURIA; REGRESSION ANALYSIS;

EID: 0028887054     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a090918     Document Type: Article

References (76)

1. Mitch WE, Walser M, Buffington GA, Lemann J. A simple method for estimating progression of chronic renal failure. Lancet 1976; 298: 122-126
2. Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney lnt 1989; 35:670-674
3. Brazy PC, Fitzwilliam JF. Progressive renal disease: role of race and antihypertensive medications. Kidney lnt 1990; 37: 1113-1119
4. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br MedJ 1987; 294: 1443-1447
5. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney lnt 1990; 38: 384-394
6. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney lnt 1971; 31: 673-689
7. Viberti GC, Hill RD, Jarret RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430-1432
8. Hunt LP, Short CD, Mallick NP. Prognostic indicators in patients with the nephrotic syndrome. Kidney lnt 1988; 34: 382-388
9. Williams PS, Fass G, Bone JM. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med 1988; 252: 343-354
10. El Nahas AM, Masters-Thomas A, Brady SA et al. Selective effect of low protein diets in chronic renal diseases. Br Med J 1984; 289: 1337-1341
11. Praga M, Hernandez E, Montoyo C, Andres A, Ruilope LM, Rodicio JL. Long-term beneficial effects of ACE inhibition in patients with nephrotic proteinuria. Am J Kidney Dis 1992; 20: 240-248
12. Gansevoort RT, de Zeeuw D, de Jong PE. Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease. Am J Kidney Dis 1993; 22: 202-206
13. Apperloo AJ, de Zeeuw D, de Jong PE. Short-term antiproteinuric response to antihypertensive treatment predicts longterm GFR decline in patients with non-diabetic renal disease. Kidney lnt 1994; 45: SI74-178
14. Rossing P, Hommel E, Smidt UM, Parving HH. Reduction in albuminuria predicts diminished progression in diabetic nephropathy. Kidney lnt 1994; 45: S145—S149
15. Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990; 33: 470-476
16. Valentino VA, Wilson MD, Weart W, Bakris GL. A perspective on converting enzyme inhibitors and calcium channel antagonists in diabetic renal disease. Arch lnt Med 1991; 151: 2367-2372
17. Friedman PJ, Dunn PJ, Jury DR. Metoprolol and albumin excretion in diabetes. Lancet 1986; 2: 1042-1043
18. Christensen CK, Mogensen CE. Effect of antihypertensive treatment on progression of incipient diabetic nephropathy. Hypertension 1985; 7 [Suppl II]: 109-113
19. Demarie BK, Bakris GL. Effect of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 113: 987-988
20. Bretzel RG, Bollen C, Maeser E, Federlin K. Hemmung der Progression der Nephropathie bei Typ-I und Typ-II-Diabetikem durch antihypertensive Therapie mit Nitrendipin. Nieren Hochdruckkr 1991; 20: 393
21. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-872
22. Remuzzi G, Ruggenenti P. Slowing the progression of diabetic nephropathy. N Engl J Med 1993; 11: 1496-1497
23. de Jong PE, Heeg JE, Apperloo AJ, de Zeeuw D. The antiproteinuric effects of blood pressure lowering agents: differences between non-diabetics and diabetics. J Cardiovasc Pharmacol 1992; 19. S28-S32
24. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-138
25. Weidmann P, Boehlen LM, de Courten M. Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 1993; 8: 582-584
26. DerSimonian R, Laird NM. Evaluating the effect of coaching on SAT scores: a meta-analysis. Harvard Educ Rev 1983; 53: 1-15
27. Cappuccio FP, Siani A, Strazzullo P. Oral calcium supplementation and blood pressure: an overview of randomized controlled trials. J Hyperlens 1991; 7: 941-946
28. Apperloo AJ, de Zeeuw D, Sluiter HE, de Jong PE. Differential effects of enalapril and atenolol on proteinuria and renal hemodynamics in non-diabetic renal disease. Br Med J 1991; 303: 821-824
29. Baba T, Murabayashi S, Takebe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin dependent) diabetic patients with microalbuminuria: a randomized trial. Diabetologia 1989; 32: 40-44
30. Bakris GL. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 112: 707-708
31. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney lnt 1992; 41: 912-919
32. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension. Am J Hypertens 1991; 4: 291-296
33. Bianchi S, Bigazzi R, Baldari G, Campese VM. Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 1-year follow-up. Am J Nephrol 1991; 11: 131-137
34. Bianchi S, Bigazzi R, Baldari G, Campese VM. Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs. Am J Med 1992; 93: 525-528
35. Bjorck S, Mulec H, Johnsen SA, Nyberg G, Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Br Med J 1990; 300: 904-907
36. Chan JCN, Cockram CS, Nicholls, Cheung CK, Swaminathan R. Comparison of enalapril and nifedipine in treating noninsulin dependent diabetes associated with hypertension: one year analysis. Br Med J 1992; 305: 981-985
37. De Cesaris R, Ranien G, Filitti V, Andriani A, Bonfantino MV. Effects of atenolol and enalapril on kidney function in hypertensive diabetic patients. J Cardiovasc Pharmacol 1993; 22: 208-214
38. Elving LD, de Nobel E, van Lier HJJ, Thien T. A comparison of the hypotensive effects of captopril and atenolol in the treatment of hypertension in diabetic patients. J Clin Pharmacol 1989; 29: 316-320
39. Erley CM, Harrer U, Kraemer BK, Risler T. Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor. Kidney lnt 1992; 41: 1297-1303
40. Erley CM, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs. Hypertension 1993; 21: 810-815
41. Ferder L, Daccordi H, Martello M, Panzalis M, Inserra F. Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients. Hypertension 1992; 19 [Suppl 2]: 237-242
42. Fioretto P, Frigato F, Velussi M et al. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients. Am J Hypertens 1992; 5: 837-846
43. Flack JR, Molyneaux L, Willey K, Yue DK. Regression of microalbuminuria: results of a controlled study, indapamide versus captopril. J Cardiovasc Pharmacol 1993; 22 [Suppl 6]: 75-77
44. Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes. Br Med J 1993; 306: 175-182
45. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987; 32: 78-83
46. Heeg JE, de Jong PE, van der Hem GK., de Zeeuw D. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 1989; 36: 272-279
47. Holdaas H, Hartmann A, Lien MG et al. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Intern Med 1991; 229: 163-1790
48. Ikeda T, Nakayama D, Gomi T, Sakurai J, Yamazaki T, Yuhara M. Captopril, an angiotensin converting enzyme inhibitor, decreases proteinuria in hypertensive patients with renal disease. Nephron 1989; 52: 72-75
49. Jenkins DAS, Cowan P, Patrick AW, Clarke BF. Renal response to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study. Nephrol Dial Transplant 1993; 8: 200-205
50. Kibnya MG, Khan AR, Jasmine F. Effect of captopril and nifedipine on kidney function and proteinuria in non-insulin dependent diabetes-melhtus (NIDDM) with nephropathy. Bangladesh Renal J 1989; 8: 48-53
51. Kloke HJ, Wetzels JFM, van Hamersvelt HW, Koene RAP, Kleinbloesem CH, Huysmans FThM. Effects of nitrendipine and cilazapril on renal hemodynamics and albuminuria in hypertensive patients with chronic renal failure. J Cardiovasc Pharmacol 1990; 16: 924-930
52. Kloke HJ, Wetzels JFM, van Hamersvelt HW, Koene RAP, Huysmans FTM. Angiotensin-converting enzyme inhibition and the combination of a beta-blocker and a diuretic are equally effective in lowering proteinuria in patients with glomerulonephritis. Nephrol Dial Transplant 1993; 8: 808-813
53. Lacourciere Y, Nadeau A, Poirier L, Tancrede G. Captopril or conventional therapy in hypertensive type II diabetics. Hypertension 1993; 21: 786-794
54. Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 1991; 302: 210-216
55. Mimran A, Insua A, Ribstein J, Monnier L, Bringer J, Mirouze J. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertens 1988; 6: 919-923
56. Moerlin C, Baglivo H, Boeijinga JK et at. Comparative trial of lisinopril and nifedipine in mild to severe essential hypertension. J Cardiovasc Pharmacol 1987; 9 [Suppl 3] S48-S52
57. Norgaard K, Jensen T, Christensen P, Feldt-Rasmussen B. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension. Blood Pressure 1993; 2: 301-308
58. O'Donnel MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive. macroproteinuric diabetic patients: a randomized double-blind study. J Human Hypertens 1993; 7- 333-339
59. Okdmura M, Kanayama Y, Negoro N, Inoue T, Takeda T. Long-term effects of calcium antagonists and angiotensinconverting enzyme inhibitors in patients with chronic renal failure of IgA nephropathy. Contrih Nephrol 1991; 90: 161-165
60. Piccoli A, Favaro E, Piva M et al The progression rate of chronic renal failure with hypertension and proteinuria can be slowed by treatment with angiotensin converting enzyme inhibitors. Curr Ther Res 1993; 53 (3): 309-315
61. Rekola S, Bergstrand A, Bucht H. Deterioration rate in IgA nephropathy, comparison of a converting enzyme inhibitor and beta-blocking agents. Nephron 1991; 59: 57-60
62. Romero R, Salinas I, Lucas A, Teixido J, Audi L, Sanmart A. Comparative effects of captopril versus nifedipine on proteinuria and renal function of type 2 diabetic patients. Diabetes Res Clin Pract 1992; 17: 191-198
63. Rosenberg ME, Hostetter TH. Comparative effects of antihypertensives on proteinuria: angiotensin-converting enzyme inhibitor versus 2,-antagonist. Am J Kidney Dis 1991; 18: 472-482
64. Samuelson O, Hedner T, Ljungman S, Herlitz H, Widgren B, Pennert K. A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and hemodynamics in uncomplicated, primary hypertension. Eur J Clin Phamacol 1992; 43. 469-475
65. Slapater R, Vicknair N, Sadler R, Bakris GL. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993; 153: 973-980
66. Stornello M, Valvo EV, Scapatello L. Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol 1989; 14: 851-855
67. Stornello M, Valvo EV, Scapatello L. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria. Nephron 1991; 58: 52-57
68. Zuchelli P, Zuccala A, Borghi M et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992; 42: 452-458
69. De Jong PE, Anderson S, de Zeeuw D. Glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome? J Am Soc Nephrol 1993; 3: 1333-1341
70. Morelli E, Loon N, Meyer T, Peters W, Meyers BD. Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39: 76-82
71. Wiegmann TB, Gish Herron M, Chonko AM, MacDougall ML, Moore WV. Effect of angiotensin-converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39: 76-82
72. Thomas DM, Hills AN, Coles GA, Davies M, Williams JD. Enalapril can treat proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics. Am J Kidney Dis 1991; 18: 38-43
73. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991; 39: 1267-1273
74. Demarie BK, Bakris GL. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 113: 987-988
75. Wight JP, Brown CB, El Nahas AM. Short-term effects of calcium antagonists on renal hemodynamics in patients with chronic renal failure. Nephron 1991; 58: 62-67
76. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19: 410-415